Oriental Aromatics Ltd Q4 FY2026 Concall Summary

Key Takeaways

• Revenue milestone, margin trough: FY26 crossed ₹1,030 crore revenue but consolidated EBITDA margin compressed to 6.60% from 10.06%, hit by a triple shock of raw material inflation, currency depreciation and Mahad ramp-up drag.
• Input cost crisis is structural, not cyclical: Gum turpentine, CST and alpha-pinene sit at all-time highs; crude-based raw materials are firm and scarce; the rupee has depreciated substantially. Management believes the worst is still not over.
• Mahad is the swing factor: The new facility remains a 1–1.5% drag on consolidated EBITDA margins, but commercial shipments have begun, global RFQ qualification is in hand, and 75–80% utilization is targeted within a year.
• Camphor overcapacity is a homegrown problem: Indian synthetic camphor capacity now substantially exceeds expected demand, a challenge management says is bigger than Chinese natural camphor imports.
• What to watch next quarter: Whether price increases passed to customers hold in a buyer’s market, the pace of Mahad’s commercial ramp-up, and any sign that raw material costs have peaked.

The Margin Compression: Three Shocks, One Drag

• Triple input-cost shock: Gum turpentine, CST and alpha-pinene prices rose through the last two quarters to all-time highs; crude oil volatility made crude-based raw materials both firm and difficult to procure; the Indian rupee depreciated substantially, inflating the import portion of the raw material basket across all three divisions.
• Pricing pass-through executed, but fragile: Price increases have been passed on to customers, yet how those customers manage in a buyer’s market in coming quarters remains to be seen.
• Aroma Ingredients structurally pressured: Chinese capacity overhang continues to flow into non-tariff markets including India, Southeast Asia and parts of Europe, keeping end-product pricing subdued globally.
• Fragrance raw material relief has reversed: The benefit of softer pricing on key fragrance raw materials has largely tapered off as input costs firmed up significantly in H2 and especially Q4.
• Consumer caution compounds the squeeze: Macroeconomic uncertainty has made consumers cautious; fragrances and flavors are perceived at the margin as discretionary even though they are embedded in everyday FMCG products.
• Sequential improvement, not recovery: Q4 EBITDA margin improved to 6.89% from 5.26% in the previous quarter, and the company swung to a ₹3.98 crore PAT from a ₹1.92 crore loss, but the underlying cost environment remains hostile.

Satoskar: "Gum turpentine, CST and alpha-pinene prices continue to go up in the last two quarters and currently are at their all-time highest ever... I think the third and very important element of the shock has been the performance of the Indian currency."

Mahad: The Strategic Bet That Is Still Costing Money

• The drag: Mahad continues to be a 1% to 1.5% headwind on consolidated EBITDA margins and was the primary reason for the ~0.98 bps reduction in consolidated net profit margins annually.
• The progress: Product acceptance is positive, sampling cycles have been completed with several global customers, and commercial shipments have commenced. The facility has also qualified to submit bids for certain global RFQs for the second half of 2026.
• The timeline: The sample-to-commercial supply cycle runs about six to nine months; management reports the facility is progressing successfully along that timeline. If allocation is received from global RFQs for H2 2026, it would help ramp up capacity further.
• The utilization target: Management is confident that within the next year, utilization of 75% to 80% should be achieved, at which point the plant becomes EBITDA-neutral and starts contributing.
• The capex math: Total investment is around ₹90 crore, but ₹20–27 crore was for a utility base that is not plant-specific, so plant-specific investment is ₹70–75 crore. At full capacity, revenue is estimated at ₹60–65 crore at current prices.
• Capacity doubling on hold: Once current Mahad capacity is reset and utilization is achieved, management will plan for another round of capacity doubling, but no timeline is committed.

Satoskar: "Mahad for Oriental Aromatics is a strategic long-horizon investment, and we remain committed to seeing it through."

Camphor & Terpene Chemicals: Overcapacity Is the Real Problem

• Indian overcapacity, not Chinese imports: Management stated that the massive demand-supply gap in India itself is the primary challenge. Substantial capacities for synthetic camphor have been built in India way above expected demand in coming years. Unless a massive reorganization of Indian camphor capacity happens, the challenge is significant and is not primarily from Chinese natural camphor imports.
• Natural camphor has operational disadvantages: Natural camphor carries disadvantages in formulations, which limits its competitive threat relative to synthetic, but the domestic synthetic overcapacity remains unresolved.
• Bareilly utilization healthy, but seasonal: The Bareilly facility operated at healthy utilization throughout the year, though Q4 is seasonally softer for camphor after festive demand in Q2 and Q3.
• Government dialogue initiated: The company has initiated dialogue twice with the central government on increasing import duty or banning natural camphor imports. Imports from China have decreased considerably compared to the last two years.
• GST evasion question deflected: When an analyst asked about steps taken to address GST evasion by competitors in North India and Chennai markets where material is available without GST, management declined to answer, stating "we cannot comment on them."

Working Capital & Balance Sheet

• Receivables stretched by global customers: Trade receivables rose almost 40% against 11% top-line growth because top global customers requested extended credit periods as part of their own cash flow management. Management stated that prices were adjusted to ensure the additional cost of money for the extra credit is covered, and debtors remain top-class quality.
• Inventory built deliberately: Conscious steps were taken in the last 1.5–2 months to overstock materials across all three verticals due to potential challenges in availability or pricing of petro streams.
• MSME payables up on better pricing: Buying from MSMEs has increased because the company is getting price benefits, so reach has increased.
• Consolidated tax rate optically high: The consolidated tax rate appears high because of the subsidiary loss; the standalone tax rate is 25%.
• Dividend maintained: The board recommended a final dividend of ₹0.50 per equity share for FY26, subject to shareholder approval at the AGM.

Revenue Mix & Volume Dynamics

• Revenue crossed ₹1,000 crore: FY26 marked the first year crossing the ₹1,000 crore revenue mark, reaching ₹1,030 crores, achieved in what management described as a challenging industry year.
• Volume growth despite pricing pressure: Healthy volume growth of 9% in sales and 5% in production was achieved despite sustained pricing and demand pressure, attributed to a diversified product portfolio across three divisions and long-standing customer relationships.
• Q4 production declined: Total production volume declined 7% QoQ and 14% YoY, primarily driven by lower production in the Specialty Chemicals division due to product mix change and trial runs or production of new product intermediates.
• Revenue mix stable at one-third each: Five years ago and currently, revenue stays roughly one-third, one-third, one-third across divisions; when one division goes up, others catch up. The domestic-international mix has shifted as global business in the aroma ingredient space contracted under pricing pressure, while the fragrance division captured substantial business with local accounts across all customer ranges.
• Peak revenue from existing assets: At current price realizations excluding Mahad, revenue can easily reach between ₹1,200 crores to ₹1,250 crores. Mahad at full capacity adds around ₹60–65 crores of additional revenue.
• Seasonal pattern: Q2 and Q3 are strong quarters due to festivals; Q4 is seasonally slow; Q1 is the ramp-up period for the festive season.

Strategy & Posture

• Consolidation mode: Management is currently in consolidation mode, with the team focused on extracting maximum benefits from investments made in the last five years. The company is open to expansion ideas, but consolidation, profit preservation and growth with current assets is the underlying theme.
• Internal efficiency programs underway: Benefits from internal cost and process improvement initiatives will accrue progressively through FY27, aimed at rebuilding margins structurally independent of the pricing cycle.
• India-US tariff overhang easing: The overhang has eased compared to the earlier part of FY26, which should support a gradual recovery in order flow from North America.
• H2 FY26 RFQ cycles constructive on volumes: Management noted that RFQ cycles for H2 FY26 look constructive on volumes, though pricing continues tight.
• No FY27 top-line guidance: When asked for FY27 top-line guidance, management declined to give a number, calling it a "crystal ball question" and stating they cannot back it up.

Satoskar: "We are open to ideas for expansion and the P&L gives us the ability to do so, but consolidation, profit preservation and growth with our current assets is the underlying theme for the team."

Guidance & Commitments

Key Metrics